News
A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists ...
We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...
Although coverage restrictions remain in place, the trendiness of weight loss drugs may be creating a growing cost concern ...
GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...
Another challenge is brewing for restaurants. It’s not the economy, another global disease, or a weather disaster. It’s the ...
The percentage of adult patients with a diagnosis of overweight or obesity increased from 10.4% in 2019 to 15.7% in 2024.
The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...
Ozempic and other GLP-1 drugs have forever altered the way people view, manage, and speak about obesity. However, it’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback